• Platform

  • Aktiesparekonto

  • Priser

  • Blog

  • MCP

  • Support

  • Populære aktier

InstagramLinkedInTikTokFacebook
Opret konto
Få appenScan koden
QR-kode til download af Endavu-appen
Log ind
GEN
Genomed
Warsaw Stock Exchange

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I GENOMED MED ENDAVU: Køb Genomed ($GEN) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Genomed, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Genomed SA is a Polish biotechnology company focused on DNA and RNA sequencing, genetic analysis, DNA synthesis, and molecular diagnostics. Genomed SA provides services for research centers, universities, biotechnological companies, clinics, laboratories, and individual clients, supporting both scientific work and medical testing. Its core offering includes sequencing-based diagnostics for inherited and genetic diseases, with applications in areas such as prenatal testing, oncology predisposition, infertility, cystic fibrosis, neurological disorders, and other clinically relevant conditions. The company uses next-generation sequencing technologies to process genetic information and develop modern diagnostic solutions for personalized medicine. Headquartered in Warsaw, Genomed SA operates in the healthcare and life sciences market, where it serves as a specialized provider linking advanced genomics with practical laboratory and medical services.

Information

TickerGEN
Land
Polen
Antal medarbejdere58
Hjemmesidegenomed.pl
SektorSundhed
IndustriDiagnostik og forskning

Udbytter

1PLN
'19
1,5PLN
'26
Ex-udbytte-dato6. jul. 2026
Udbytteafkast4,05%